Introduction
Perimenopause in the workplace is a high-risk area where medical support often intersects with harmful stereotypes. This article analyzes the theses from the book The Hormone Loop, highlighting the dangers of over-institutionalizing the problem.
Readers will learn how to support women during this period without limiting their agency. You will be introduced to the life-course compatible workplace model, which replaces ad hoc systemic benefits with organizational resilience toward the biological variability of employees.
Medical Support Over HR Categorization
The author argues that supporting women should not involve creating a new category of "menopausal employee." Such an approach reinforces stereotypes regarding decreased productivity and leads to statistical discrimination, where age becomes a predictor of professional risk.
To avoid stigmatization, support should be based on proportionate universalism. This means ensuring high-quality conditions for everyone while increasing the intensity of assistance for those with a genuine need. An example is flexible working hours, which serve parents and the ill alike without labeling anyone as "deficient."
Separating Medical Diagnosis from Functional Adjustments
An employer's role ends at removing barriers in the work environment; it does not extend to hormonal diagnostics. The author emphasizes that HR should not offer advice on treatment, as this violates medical privacy and a woman's dignity.
The key is to separate the diagnosis from the functional limitation. An employer does not need to know the details of a cycle or therapy, only the scope of the recommendations (e.g., the need for more frequent breaks). Such a mechanism protects against bias during promotions and prevents paternalism, which strips women of their agency in the name of superficial protection.
Equal Treatment Requires Separating Results from Presence
In light of equal treatment laws, organizations should replace the standard of presence (e.g., long hours spent in the office) with a standard of results. The author notes that the ideal worker model often discriminates against individuals with temporary biological limitations.
To avoid discrimination, diagnosis-neutral solutions should be implemented: transparent promotion criteria and a culture based on outcomes. This prevents so-called career hysteresis, or the permanent loss of professional opportunities even after symptoms have subsided. Support must therefore guarantee not only a return to work, but above all, a return to opportunity.
Summary
The professional success of middle-aged women depends on how institutions respond to their variability. The true test of a modern organization is not the presence of a "menopause-friendly" program, but rather its ability to decouple physiology from potential.
Building a system resilient to biological variability avoids the trap where a temporary health symptom becomes a lifelong sentence for one's career. Ultimately, the goal is to ensure agency without guilt and to protect human capital from essentialism.
Frequently Asked Questions
How to help women during perimenopause without simultaneously creating harmful professional stereotypes?
Helping women during perimenopause should be based primarily on the healthcare system rather than HR departments, in order to avoid stereotypes regarding lower employee productivity. It is key to ensure access to reliable differential diagnostics and individually tailored treatment based on medical evidence.
1. Where does the employer's role end and a woman's medical privacy begin during perimenopause?
2. The employer's role is limited to providing an appropriate work environment and removing barriers to accessing care, rather than medical management or hormonal diagnostics. A woman's privacy is protected by the right to disclose only necessary information regarding functional needs (e.g., modification of working hours), without the need to provide details about her health status.
3. Are menopause-related difficulties in the workplace subject to legal protection, and how should organizations approach them to avoid discriminating against women?
4. Menopause-related difficulties are protected against direct and indirect gender discrimination under EU law and the Polish labor law system. To avoid discrimination, organizations should verify whether job requirements are functionally necessary rather than resulting merely from cultural rituals, and consider implementing a broad life-course health policy that includes flexibility and workplace adaptation.
5. What should manager training on perimenopause look like to ensure it does not worsen women's professional situations?
6. Training should emphasize the heterogeneity of symptoms rather than a catalog of deficits, teaching managers to respond to reported functional needs instead of diagnosing subordinates. It must build awareness that menopausal status is not a predictor of work ability and that medical knowledge cannot be used to assess individual potential.
7. How can a stigmatizing approach to supporting women during menopause in the workplace be avoided?
8. Biological knowledge should be used to increase women's actual opportunities for professional activity, avoiding paternalism and the restriction of their choices. It is worth introducing general standards regarding time flexibility and ergonomics through social dialogue, which prevents support from depending on individual negotiations or a supervisor's sympathies.
9. How can women during menopause be supported at work without creating stigmatizing categories or limiting their professional opportunities?
10. Support should be based on general principles of health management, flexibility, and equal opportunity, as well as occupational medicine that moves away from a binary model of work ability. Easy access to help and education should be provided, while avoiding mandatory screening, automatic reduction of professional workloads, or the promotion of specific medical therapies.
Instead of creating special programs for women in menopause, would it be better to introduce general systemic changes within the organization?
Systemic and diagnosis-neutral interventions, such as transparent promotions or flexibility in performance evaluation instead of a culture of physical presence, are far better justified. These solutions are more universal than policies based on a single medical category and build organizational resilience to the natural variability of all employees.
How can one verify whether support programs for women in menopause within a company actually work, rather than being merely a PR exercise?
It is necessary to examine real changes in knowledge levels, sense of security, and employee retention, and to check whether utilizing support does not lead to negative professional consequences. It is important to analyze whether the program serves only to build the company's image (policy performativity) and whether it is accessible to all employee groups, not just privileged individuals.
Should support for women in menopause be a corporate benefit or an element of the healthcare system and state policy?
Menopausal health is a component of public health; therefore, care in this area should be part of the healthcare system and state policy, rather than a luxury corporate benefit. An employer can improve access to support and inform about the need for consultations, but should not replace the public system or promote specific therapies.
How can we avoid situations where temporary health problems related to perimenopause become a permanent barrier to a woman's professional development?
A policy should be introduced to monitor not only the return to work, but above all the 'return to opportunity,' ensuring women maintain access to promotions, training, and projects. This requires coordination between medicine, the state, and organizations so that temporary health difficulties do not become a permanent institutional penalty.
How should women in menopause be supported so that it does not become a basis for their professional discrimination or stigmatization?
Access to care, education, and workplace adaptation must be improved, while counteracting stereotyping and reputational penalties for using support. It is crucial to separate health risks from competency assessments, ensuring women are promoted without assumptions regarding their reproductive age.
How to create a work system that supports women in perimenopause without doing so at the expense of their career opportunities and without stigmatization?
A life-course compatible workplace should be created, based on a universal architecture of rights and procedures that allow for temporary adaptation while maintaining identical promotion standards. The key is combining specific medical knowledge about perimenopause with an individual approach, which allows for compensating transient costs without creating stereotypes or permanently lowering career prospects.
